Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 376 Polycystic Ovary Syndrome 40 Neoplasm Metastasis 23 Endometrial Neoplasms 22 Ovarian Neoplasms 16 Neoplasms 14 Infertility 11 Advanced Breast Cancer 10 Fallopian Tube Neoplasms 8 Carcinoma, Intraductal, Noninfiltrating 8 Triple Negative Breast Neoplasms 7 Recurrence 7 Osteoporosis 7 Carcinoma, Ductal, Breast 7 Breast Neoplasms, Male 7 Breast Diseases 7 Carcinoma, Lobular 6 Breast Carcinoma In Situ 6 Prostatic Neoplasms 5 Leiomyoma 4 Infertility, Female 4 Hereditary Sensory and Autonomic Neuropathies 4 Breast Cancer Metastatic 4 Arthralgia 4 Obesity 3 Neoplasms, Hormone-Dependent 3 Carcinoma, Ovarian Epithelial 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Neoplasms 2 Uterine Cervical Neoplasms 2

Interventions

bicalutamide 5 enzalutamide 4 exemestane 2 darolutamide 2 abiraterone 2 pembrolizumab 1 ostarine 1 nilutamide 1 cabazitaxel 1 apalutamide 1 abemaciclib 1 Vorinostat 1 Triptorelin Pamoate 1 Tamoxifen 1 Prophylactic Mastectomy 1 Prednisolone 1 Panobinostat 1 Mifepristone 1 Letrozole 1 Histamine H2 Antagonists 1 Histamine Antagonists 1 Goserelin 1 Doxorubicin 1 Docetaxel 1 Dasatinib 1 Cisplatin 1 CP protocol 1 Aromatase Inhibitors 1 Antiemetics 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Bulbo-Spinal Atrophy, X-Linked × Letrozole × Clear all

NCT02910050 2017-12-22

BETTER

Sun Yat-sen University

Phase 2 Unknown

Breast Neoplasms, Bulbo-Spinal Atrophy, X-Linked

Data powered by HemOnc (CC BY 4.0) Colophon ⚡